Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-09

FDA Approved: FENOFIBRATE — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Alembic's fenofibrate as an Original Application (ANDA). The generic fenofibrate is approved for treating lipid disorders such as hyperlipidemia, h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

ORIG AP for FENOFIBRATE (FENOFIBRATE)